Last reviewed · How we verify
L+C maxillary anesthesia
L+C maxillary anesthesia is a local anesthetic formulation designed to provide regional anesthesia in the maxillary region of the oral cavity.
L+C maxillary anesthesia is a local anesthetic formulation designed to provide regional anesthesia in the maxillary region of the oral cavity. Used for Maxillary regional anesthesia for dental and oral surgical procedures.
At a glance
| Generic name | L+C maxillary anesthesia |
|---|---|
| Sponsor | University of Belgrade |
| Drug class | Local anesthetic combination |
| Modality | Small molecule |
| Therapeutic area | Anesthesia / Dentistry |
| Phase | Phase 3 |
Mechanism of action
This drug combines local anesthetic agents (likely lidocaine and another agent such as articaine or prilocaine, indicated by 'L+C') to achieve rapid onset and sustained duration of anesthesia in maxillary dental and oral surgical procedures. The combination formulation aims to optimize both the speed of anesthetic effect and the duration of pain relief in the upper jaw region.
Approved indications
- Maxillary regional anesthesia for dental and oral surgical procedures
Common side effects
- Transient paresthesia
- Allergic reaction
- Injection site discomfort
- Systemic toxicity (if overdosed)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- L+C maxillary anesthesia CI brief — competitive landscape report
- L+C maxillary anesthesia updates RSS · CI watch RSS
- University of Belgrade portfolio CI